Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Innocan Pharma Corp. buy Bobysh

Innocan Pharma Corp.
Start price
€0.20
24.03.24 / 50%
Target price
€0.80
24.03.25
Performance (%)
-38.69%
End price
€0.12
24.12.24
Summary
This prediction ended on 24.12.24 with a price of €0.12. Massive losses of -38.69% were the result for the BUY prediction by Bobysh. Bobysh has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Innocan Pharma Corp. - - -
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

According to Bobysh what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by Bobysh for this prediction

In the thread Innocan Pharma Corp. diskutieren
Prediction Buy
Perf. (%) -38.69%
Target price 0.800
Change
Ends at 24.03.25

Buy mit Kursziel 0,8

Bobysh 
0
Report Share
24.03.24

Stopped prediction by Bobysh for Innocan Pharma Corp.

buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.20
13.12.22
€1.30
13.12.23
9.03%
14.12.23

Could be very worthwhile Investment >20% year
Bobysh 
13.12.22 50%
buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.39
25.07.22
-
25.08.22
-2.21%
26.08.22

Could be very worthwhile Investment >20% year
Bobysh 
25.07.22 50%
buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.36
17.05.21
€0.80
17.05.22
26.23%
18.01.22

Could be very worthwhile Investment >20% year
Bobysh 
17.05.21 50%